Glenbrook Capital Management Purchases 10,000 Shares of Senestech (NASDAQ:SNES) Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 10,000 shares of the company’s stock in a transaction dated Monday, May 18th. The stock was bought at an average cost of $1.59 per share, for a total transaction of $15,900.00. Following the completion of the transaction, the insider owned 925,755 shares in the company, valued at approximately $1,471,950.45. This represents a 1.09% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, May 15th, Glenbrook Capital Management purchased 7,120 shares of Senestech stock. The stock was bought at an average cost of $1.65 per share, for a total transaction of $11,748.00.
• On Thursday, May 14th, Glenbrook Capital Management purchased 15,000 shares of Senestech stock. The stock was bought at an average cost of $1.72 per share, for a total transaction of $25,800.00.
• On Tuesday, April 28th, Glenbrook Capital Management purchased 3,000 shares of Senestech stock. The stock was bought at an average cost of $1.47 per share, for a total transaction of $4,410.00.
• On Tuesday, March 17th, Glenbrook Capital Management purchased 19,725 shares of Senestech stock. The stock was bought at an average cost of $1.79 per share, for a total transaction of $35,307.75.
• On Monday, March 16th, Glenbrook Capital Management purchased 5,060 shares of Senestech stock. The stock was bought at an average cost of $1.86 per share, for a total transaction of $9,411.60.
• On Friday, March 13th, Glenbrook Capital Management purchased 146,249 shares of Senestech stock. The stock was bought at an average cost of $1.95 per share, for a total transaction of $285,185.55.
• On Thursday, February 19th, Glenbrook Capital Management purchased 34,613 shares of Senestech stock. The stock was bought at an average cost of $2.40 per share, for a total transaction of $83,071.20.
• On Wednesday, February 18th, Glenbrook Capital Management purchased 10,481 shares of Senestech stock. The stock was bought at an average cost of $2.29 per share, for a total transaction of $24,001.49.
• On Tuesday, February 17th, Glenbrook Capital Management purchased 40,807 shares of Senestech stock. The stock was bought at an average cost of $2.29 per share, for a total transaction of $93,448.03.

Senestech Stock Performance

Shares of SNES opened at $1.53 on Wednesday. The company has a quick ratio of 7.79, a current ratio of 8.91 and a debt-to-equity ratio of 0.02. The business’s 50 day moving average price is $1.69 and its 200-day moving average price is $2.15. Senestech, Inc. has a 52 week low of $1.41 and a 52 week high of $6.24. The stock has a market cap of $8.11 million, a P/E ratio of -0.81 and a beta of 0.18.

Senestech (NASDAQ:SNES) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($0.31) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.02. Senestech had a negative return on equity of 67.60% and a negative net margin of 304.22%.The firm had revenue of $0.49 million for the quarter, compared to analysts’ expectations of $0.63 million. Equities research analysts anticipate that Senestech, Inc. will post -1.61 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a report on Friday, March 27th. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold”.

Key Headlines Impacting Senestech

Here are the key news stories impacting Senestech this week:

• Positive Sentiment: Major shareholder Glenbrook Capital Management continued buying shares, including recent purchases at $1.59 to $1.72, while CEO Michael Edell also bought shares. Insider buying can signal confidence in Senestech’s outlook. Glenbrook Capital Management Acquires 7,120 Shares of Senestech (NASDAQ:SNES) Stock
• Positive Sentiment: Senestech announced it will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, which could help increase investor visibility and potentially generate interest in the stock. SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
• Neutral Sentiment: The company’s latest quarterly report showed a smaller-than-expected loss of $(0.31) per share, but revenue came in below estimates at $0.49 million, leaving the operating trend weak despite the EPS beat.
• Negative Sentiment: HC Wainwright lowered near-term earnings estimates for Senestech, including Q2 2026, Q3 2026, and Q4 2026, reflecting weaker expectations for profitability in the coming quarters.
• Negative Sentiment: The analyst firm also raised its loss forecasts for FY2026, FY2027, and FY2028, which may reinforce concerns about Senestech’s path to sustained earnings improvement.

Hedge Funds Weigh In On Senestech

A number of hedge funds have recently added to or reduced their stakes in SNES. Geode Capital Management LLC purchased a new position in Senestech in the 2nd quarter worth approximately $59,000. Jane Street Group LLC purchased a new stake in Senestech during the 2nd quarter valued at $161,000. Essex Investment Management Co. LLC purchased a new stake in Senestech during the 3rd quarter valued at $115,000. Sabby Management LLC purchased a new stake in Senestech during the 3rd quarter valued at $313,000. Finally, Millennium Management LLC purchased a new stake in Senestech during the 3rd quarter valued at $126,000. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.